CIK 0001801170
- Large accelerated filer
CLOVER HEALTH INVESTMENTS, CORP. /DE
Sign in to watch- Ticker
- CLOV
- Exchange
- Nasdaq
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 981515192
- Phone
- +1 201-432-2133
- Business address
- 30 MONTGOMERY STREET, JERSEY CITY, NJ, 07302
- Former names
- Social Capital Hedosophia Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,798,293
- in 17 filings, $3.6M under 10b5-1 plans
Net −$3,798,293. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-07 | Lee Gia General Counsel & Secretary | Grant or award · Stock Options (right to buy) | +568,720 | 568,720 | ||
| 2021-01-07 | Lee Gia General Counsel & Secretary | Grant or award · Stock Options (right to buy) | +336,062 | 336,062 | ||
| 2021-01-07 | Lee Gia General Counsel & Secretary | Grant or award · Stock Options (right to buy) | +1,008,186 | 1,008,186 | ||
| 2021-01-07 | Garipalli Vivek Chief Executive Officer | Grant or award · Class B Common Stock | +75,694,143 | 75,694,143 | ||
| 2021-01-07 | Garipalli Vivek Chief Executive Officer | Grant or award · Class B Common Stock | +182,201 | 182,201 | ||
| 2021-01-07 | Garipalli Vivek Chief Executive Officer | Grant or award · Class B Common Stock | +5,645,934 | 5,645,934 | ||
| 2021-01-07 | Garipalli Vivek Chief Executive Officer | Grant or award · Class B Common Stock | +2,062,265 | 2,062,265 | ||
| 2021-01-07 | Garipalli Vivek Chief Executive Officer | Grant or award · Performance-based Restricted Stock Units | +7,164,581 | 7,164,581 | ||
| 2021-01-07 | Garipalli Vivek Chief Executive Officer | Grant or award · Restricted Stock Units | +16,713,491 | 16,713,491 | ||
| 2021-01-07 | Garipalli Vivek Chief Executive Officer | Grant or award · Performance-based Restricted Stock Units | +5,571,164 | 5,571,164 | ||
| 2021-01-07 | Palihapitiya Chamath 10% owner | Grant or award | +10,000,000 | $10.00 | $100.0M | 10,000,000 |
| 2021-01-07 | Palihapitiya Chamath 10% owner | Exercise or conversion | +20,500,000 | 30,500,000 | ||
| 2021-01-07 | Palihapitiya Chamath 10% owner | Exercise or conversion · Class B ordinary share | −20,500,000 | 0 | ||
| 2021-01-07 | Palihapitiya Chamath 10% owner | Grant or award · Class B Common Stock | −284,891 | 0 | ||
| 2021-01-07 | Osborne Ian 10% owner | Grant or award | +5,000,000 | $10.00 | $50.0M | 5,000,000 |
| 2021-01-07 | Osborne Ian 10% owner | Exercise or conversion | +20,500,000 | 25,500,000 | ||
| 2021-01-07 | Osborne Ian 10% owner | Exercise or conversion · Class B ordinary share | −20,500,000 | 0 | ||
| 2021-01-07 | Ryans James FORMER DIRECTOR | Exercise or conversion | +100,000 | 100,000 | ||
| 2021-01-07 | Ryans James FORMER DIRECTOR | Exercise or conversion · Class B ordinary share | −100,000 | 0 | ||
| 2021-01-07 | Reses Jacqueline D FORMER DIRECTOR | Exercise or conversion | +100,000 | 100,000 |
Page 21 of 22 · 422 trades